Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Oncology Market Access & Pricing 2015, June 15- 16, Boston | Double Tree by Hilton

Reporter: Aviva Lev-Ari, PhD, RN

brochure here: 
www.eyeforpharma.com/oncologyusa/docs/brochure.pdf

These are some of the high-level speakers you’ll learn from in June:

• Edward J Benz Jr., President and CEO, Dana Farber Cancer Institute
• Ana Cespedes, SVP, Head of Global Market Access and Pricing, Merck Serono
• Kevin O’Leary, VP, Strategic Pricing and Reimbursement, Bayer
• Ted Okon, Executive Director, Community Oncology Alliance
• Christine Colby, VP, Global Medical Affairs, Millennium: The Takeda Oncology Company
• Byron Robinson, Senior Director, Global Program Head Oncology, Bayer 
• Peter Sandor, VP, Global Marketing, TA Head of Oncology, Amgen

Dont’t miss out on our special pre-registration rate valid through March 27th and save $500:
Sign up under this link: https://secure.eyeforpharma.com/oncologyusa/register.php

Please let me know if you’re interested in attending with your colleague or bring your team for a special discount!

Best,
Ulrich

____

Ulrich B. Neumann 
Director, eyeforpharma 
201 204 1688

FC Business Intelligence Ltd is a registered company in England and Wales – Registered number 04388971, 7-9 Fashion Street, London, E1 6PX, UK
This email message has been delivered safely and archived online by Mimecast.
For more information please visit http://www.mimecast.com